The Patent Finder

Janssen Alzheimer Immunotherapy

Also on record
Records under this name other than patents Janssen Alzheimer Immunotherapy holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Janssen Alzheimer Immunotherapy

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 7,625,560Humanized Antibodies That Recognize Beta Amyloid Peptide
Formerly held
In force
 · High confidence
In forceHigh confidence
US 8,784,810Treatment of amyloidogenic diseases
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 7,635,473Anti a Beta Antibody Formulation
Formerly held
In force
 · High confidence
In forceHigh confidence
US 8,506,959Prevention and Treatment of Synucleinopathic and Amyloidogenic Disease
Formerly held
In force
 · High confidence
In forceHigh confidence
US 9,272,030Use of Tau to Monitor Immunotherapy
Formerly held
In force
 · High confidence
In forceHigh confidence
US 9,644,025Immunotherapy Regimes Dependent on Apoe Status
Formerly held
In force
 · High confidence
In forceHigh confidence
US 7,820,799Methods of Purifying FC Region Containing Proteins
Term ended
Ended no later than Oct 25, 2026 · Medium confidence
Term endedEnded no later than Oct 25, 2026Medium confidence
US 7,727,957Treatment and Delay of Outset of Parkinson's Disease
Term ended
Term ended Aug 14, 2025 · High confidence
Term endedTerm ended Aug 14, 2025High confidence
US 8,357,781Neuroactive Fragments of App
Lapsed on the fee record
Ended Jan 22, 2025 · High confidence
Lapsed on the fee recordEnded Jan 22, 2025High confidence
US 9,034,337Treatment and Delay of Outset of Synucleinopathic and Amyloidogenic Disease
Formerly held
Term ended
Term ended Jan 22, 2025 · Medium confidence
Term endedTerm ended Jan 22, 2025Medium confidence
10 of 68 patents shown.
Pro members see all 68.
Pro members: see all 68 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited